Skip to main content

Assessments and measurement-based practice

Cognitive screening in practice

How a primary care or memory service can run brief cognitive screening: the Alzheimer's Association detection steps, choosing patient and informant tools, ruling out delirium and depression, and what to document.

Screening decides who needs a fuller evaluation

The Alzheimer's Association describes detecting possible cognitive impairment as the first step in deciding whether a person needs further cognitive tests and evaluation. Its recommended brief tools take about five minutes and can be given by a physician or trained staff. No single brief tool is recognised as the best, and anyone who scores in the concerning range should be evaluated further or referred. [3][1]

Follow the detection steps

The Alzheimer's Association Annual Wellness Visit algorithm (Cordell and colleagues, 2013) starts by reviewing the health risk assessment, clinician observation, self-reported concerns and answers to direct questions. When signs or symptoms are present, or when there are none but no informant is available to confirm that, the clinician carries out a brief structured assessment. [1][2]

  • Patient assessment: Mini-Cog or GPCOG.
  • Informant assessment of the patient: Short IQCODE, AD8 or the GPCOG informant interview.
  • Concerning result, patient: Mini-Cog total of 3 or less, or a GPCOG patient score below 5. A GPCOG patient score of 5 to 8 is indeterminate without an informant.
  • Concerning result, informant: Short IQCODE mean of 3.38 or more, AD8 total of 2 or more, or a GPCOG informant score of 3 or less alongside a patient score below 8. On the GPCOG form itself, the informant interview is read when the patient score is 5 to 8, because a patient score of 0 to 4 already indicates impairment.
  • If a brief assessment raises concern, refer or carry out a full dementia evaluation. If it does not, follow up at the next annual visit.
[1]

Some clinicians repeat the patient assessment with an alternate tool, such as SLUMS or MoCA, to check initial findings before referring or starting a full dementia evaluation. A longer tool adds detail; it does not make a diagnosis. [1]

Lirena original visual

From concern to a decision about further evaluation

The detection steps from the Alzheimer's Association algorithm, with the checks that make a brief score interpretable.

  • Review

    Concerns from the person, the family and the clinician, plus the health risk assessment.

  • Check

    Delirium (4AT) first, then mood (GDS-15 or Cornell Scale), sensory aids, language and education.

  • Screen

    A patient tool (Mini-Cog or GPCOG) and an informant tool (AD8, Short IQCODE or GPCOG).

  • Repeat

    Repeat a concerning result with an alternate tool such as MoCA or SLUMS.

  • Decide

    Refer or carry out a full evaluation, or follow up at the next review.

The detection steps from the Alzheimer's Association algorithm, with the checks that make a brief score interpretable. This diagram was created by Lirena for this guide.

Choose a tool for the setting and the person

The Alzheimer's Association selection criteria are an administration time of five minutes or less, validation in primary care or community settings, psychometric properties equal to or better than the MMSE, ease of use by non-physician staff, and relative freedom from educational, language and cultural bias. [3]

  • Brief primary care screens: Mini-Cog, GPCOG, 6CIT and the AMTS.
  • Longer screens for memory services: MoCA, which takes about 10 to 15 minutes, ACE-III, which takes 10 to 20 minutes and is scored out of 100, and Mini-ACE, which takes 5 to 10 minutes.
  • RUDAS was designed to reduce the effect of cultural learning and language diversity on the assessment of baseline cognition.
  • Informant tools such as AD8 and the Short IQCODE ask about change over time. That avoids some of the education effects that affect performance tests.
  • Allow for hearing or vision impairment, dysphasia and the lack of a shared language. Record the aids and interpreting that were used.
[4][3][5]

Rule out delirium and low mood before interpreting a low score

Delirium can produce a low score on any cognitive test, so check for it first. The 4AT takes under 2 minutes and needs no training. On the form, a total of 4 or more means possible delirium, with or without cognitive impairment, and is not diagnostic. A total of 1 to 3 means possible cognitive impairment, and calls for more detailed cognitive testing and informant history. A total of 0 makes delirium or severe cognitive impairment unlikely, but delirium is still possible if the information for item 4 is incomplete. Score items 1 to 3 on observation at the time of assessment. Item 4 needs information from someone who knows the person, or from the notes. [5][4]

  • Delirium is common in people who already have dementia, so a known dementia diagnosis does not rule it out.
  • When delirium is possible, postpone diagnostic cognitive testing until it has resolved. Scores obtained during delirium may not reflect the person's usual level.
  • Informant questionnaires such as the AD8 and Short IQCODE ask about change over months or years before the current episode, so they stay informative while the person is unwell.
  • The 4AT was developed and validated mainly in acute hospital settings. Its accuracy may differ in outpatient and community clinics.
[5][7]

Depression and other mood disorders can overlap with dementia symptoms, so the Alzheimer's Association recommends assessing wellbeing as part of the evaluation. A self-report mood measure such as the GDS-15 adds that context. Its validity falls as dementia becomes more severe, and the Cornell Scale for Depression in Dementia, rated from a carer interview and an interview with the person, is the usual observer-rated alternative. The GDS-15 has no item on suicidal thoughts; ask directly, or use the PHQ-9 or C-SSRS, when there is concern. [3]

Know when to refer and who else needs support

  • Inconclusive findings or an atypical presentation.
  • Behavioural or psychiatric symptoms.
  • Younger onset, under 65.
  • A request for a second opinion, patient or family preference, or a family dispute.
  • Caregiver support needs.
[3]

The Caregiver Strain Index is a 13-question measure of strain across employment, financial, physical, social and time domains. Seven or more positive responses indicate a greater level of strain, which helps identify families who may need fuller assessment and follow-up. [4]

Document the conditions of testing and plan retesting

  • The tool, its version or form, and who administered it.
  • Years of formal education and any education adjustment applied, such as the MoCA point for 12 years or less.
  • The language of testing, interpreter use, and hearing or visual aids.
  • The informant's relationship to the person and how long they have known them.
  • Delirium screening, mood context and any conditions on the day that could have affected performance.

When you repeat a test to look at change, use the published alternate forms where they exist, such as the A, B and C versions of ACE-III, to limit practice effects. Compare like with like, and set the retest interval in your local protocol. [4]

Small changes are hard to read. In one community study, an individual's score had to change by 3 or more MMSE points, or 4 or more MoCA points, before the change exceeded measurement error on retest after 2 to 4 months. [6]

Sources and further reading

  1. Medicare Annual Wellness Visit Algorithm for Assessment of Cognition (opens in a new tab)Alzheimer's Association. Accessed 2026-11-14. One-page detection algorithm with the brief-tool thresholds for patient and informant assessment.
  2. Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting (opens in a new tab)Alzheimer's & Dementia. Published 2013-03. Accessed 2026-11-14. Cordell CB, Borson S, Boustani M, et al. Alzheimers Dement. 2013;9(2):141-150. The source paper for the algorithm.
  3. Cognitive Assessment (opens in a new tab)Alzheimer's Association. Accessed 2026-11-14. Who to evaluate, brief-tool selection criteria, patient and informant tools, mood assessment and referral indications.
  4. Commonly used Cognitive Screens and Assessments (opens in a new tab)Dementia Services Information and Development Centre (dementia.ie). Accessed 2026-11-14. Summaries of MoCA, MMSE, ACE-III, Mini-ACE, RUDAS, 4AT, AD8 and the Caregiver Strain Index, with administration times.
  5. 4AT - Rapid Clinical Test for Delirium (opens in a new tab)the4at.com. Accessed 2026-11-14. Official 4AT form, scoring guidance and validation references.
  6. Measurement error, reliability, and minimum detectable change in the Mini-Mental State Examination, Montreal Cognitive Assessment, and Color Trails Test among community living middle-aged and older adults (opens in a new tab)Journal of Alzheimer's Disease. Published 2016. Accessed 2026-11-14. Feeney J, Savva GM, O'Regan C, et al. J Alzheimers Dis. 2016;53(3):1107-1114. Test-retest study in the Irish Longitudinal Study on Ageing.
  7. Dementia: assessment, management and support for people living with dementia and their carers (NG97) (opens in a new tab)National Institute for Health and Care Excellence. Published 2018-06-20. Accessed 2026-11-14. UK guideline on initial assessment, including brief structured cognitive instruments and not ruling out dementia on a normal score alone.

Next step

Run cognitive screening in Lirena

See how patient, informant and clinician-administered cognitive screens are assigned, scored and reviewed together.

Explore memory clinic workflows